Medicare Advantage Under Continued Scrutiny: The Good, The Bad, And The Uncertain
Kort samengevat
Medicare Advantage faces unprecedented regulatory scrutiny as federal agencies deploy aggressive audit strategies, Congress investigates alleged fraud schemes, and courts challenge CMS's authority over payment structures.
Verder lezen bij de bron
Bekijk het volledige nieuwsbericht rechtstreeks bij Mondaq.
Lees het volledige bericht ↗